Recognizing Radiation Therapy as Both Cause and Treatment for Cancer Pain
Estimates vary, but research has suggested that roughly 60% of patients undergoing cancer therapy experience pain.
All articles by Roi Perez
Cancer and Dementia: Managing Care of Patients With a Complex Dual Diagnosis
Dementia can profoundly complicate cancer treatment, decision making, compliance, and outcomes for elderly patients undergoing radiotherapy.
Strategies for Managing Chronic Pain in Patients With Bone-Metastatic CRPC
An overview of prostate cancer metastases to bone is presented, including strategies for pain assessment and palliative radiotherapy.
Strategies for Patient Comfort, Position Holding, and Compliance During Radiotherapy Treatments
A systematic review of studies focused on strategies to improve patient comfort and compliance with radiotherapy treatment plans, finding that aromatherapy strategies show promise in this setting.
With Rucaparib Approval, Prostate Cancer Joins the Precision Oncology Era
The FDA’s accelerated approval of the PARP inhibitor rucaparib brings clinical prostate oncology into the precision medicine era.
Stereotactic Body Radiotherapy: Past and Future Challenges
Dr Sue Yom discusses the evolution and future of stereotactic body radiotherapy.
Radiotherapy for Cervical Cancer: An Introduction to ASTRO’s Clinical Practice Guideline
The consensus guideline, drafted by an ASTRO-convened expert task force, offers recommendations about radiotherapy, including brachytherapy, and chemoradiation, in different stage-of-disease and treatment-strategy settings.
Few mHealth Apps Are Specific to Radiotherapy, But Helpful Tools Are Available
A decade since the first wave of mobile device health apps hit the market there remain few designed specifically for patients who are undergoing radiation therapy for cancer. This review offers some useful tools available for patient education, organization, and coping.
Peripheral Blood MRD Shows Promise for Assessing CLL in Patients Treated With Venetoclax
Peripheral blood sample MRD assessment will likely come into routine clinical use in the next few years, according to an expert who specializes in CLL.
Patients With Cancer Who Vape Are at Significant Risk for EVALI
A nationwide outbreak of EVALI reports has highlighted the unknowns about one of the most popular forms of inhalation drug use in the US.
- Loading...
Loading...
Next post in Lung Cancer
Loading... 
Loading...